Xiaoxiao Zhong – Mechanism of Resistance – Best Researcher Award

Xiaoxiao Zhong - Mechanism of Resistance - Best Researcher Award

the THIRD Xiangya hospital, csu - China

AUTHOR PROFILE

ORCID

🧬 ACADEMIC FOUNDATION AND EARLY INQUIRY

Dr. Xiaoxiao Zhong began her journey in molecular biology with a keen curiosity about the Mechanism of Resistance within metabolic and glandular disorders, particularly in cancer biology. Her academic training laid the foundation for decoding the intricate cellular and molecular landscapes of diseases, especially breast cancer. The Mechanism of Resistance became a recurring theme as she explored glycosylation processes and immune microenvironments during her early research. Her initial studies bridged theory and application, combining computational and experimental approaches to understand how cancers evade immune detection. These formative years equipped her with a robust understanding of translational oncology and introduced her to the emerging significance of the tumor microenvironment. Zhong's early academic success fueled her drive to pursue multidisciplinary integration—especially in bioinformatics, transcriptomics, and high-throughput data analysis. Her pursuit to reveal the Mechanism of Resistance in disease pathways began with small but significant steps, contributing to larger discoveries that would later shape her career. Her work at Central South University provided not only a supportive academic environment but also exposure to state-of-the-art research tools and collaborative frameworks. These experiences instilled in her a lifelong mission to uncover the biological processes that define cancer behavior and their connection to the Mechanism of Resistance.

đź§Ş PROFESSIONAL ADVANCEMENT IN TRANSLATIONAL RESEARCH

As a Medicine Doctor at The Third Xiangya Hospital of Central South University, Dr. Xiaoxiao Zhong steadily advanced her professional career by centering her investigations around the Mechanism of Resistance in cancer therapy. Her professional endeavors are marked by an integrative approach to both clinical and laboratory settings, where she collaborates across disciplines to identify new prognostic markers and therapeutic targets. Zhong's work delves into how dysregulated metabolic pathways contribute to the Mechanism of Resistance in breast cancer. Her projects—sixteen in number—underscore her commitment to applied research with translational outcomes. She navigates between in vitro experimentation and multi-omics bioinformatics with precision, making her work both pioneering and clinically relevant. The Mechanism of Resistance is not only a research theme but a clinical puzzle she strives to solve, influencing treatment personalization and long-term patient outcomes. As a reviewer for scientific journals and a member of national research associations, she maintains active roles in advancing oncology research. Her contribution to the General Program of the National Natural Science Foundation of China reflects her recognition as a key scientific mind. Through it all, the Mechanism of Resistance remains central to her objectives, shaping the way future therapies may overcome cancer’s most persistent barriers.

🔬 RESEARCH INNOVATION AND DISCOVERY FOCUS

Dr. Xiaoxiao Zhong’s innovative research revolves around decoding the tumor microenvironment (TME) and understanding the Mechanism of Resistance that allows cancer cells to evade immune surveillance and therapeutic interventions. Her groundbreaking development of the 22-gene TME-risk signature (TMERS) has proven instrumental in advancing prognostic predictions in breast cancer. She consistently focuses on the Mechanism of Resistance embedded in glycosylation processes and immune evasion tactics, providing a dual-layered analysis that merges structural biology with immune profiling. Zhong’s research innovations also explore the role of key glycosyltransferase genes like KLRB1, whose regulatory influence she established through rigorous functional assays. Her integration of WGCNA, LASSO Cox regression, and DEG analysis demonstrates her mastery of both computational tools and biological insight. By repeatedly returning to the Mechanism of Resistance across different datasets and models, Zhong reinforces the centrality of this concept in cancer biology. Her studies do not merely describe pathways—they clarify function and mechanism. Moreover, these findings create pathways to new therapeutic interventions, especially in tumors that exhibit high resistance profiles. Zhong’s innovative strategy of combining multi-omics and experimental models ensures that her contributions remain at the frontier of cancer research, with the Mechanism of Resistance as her guiding lens.

đź§  IMPACT ON ONCOLOGY AND BIOMARKER DEVELOPMENT

The clinical and research community has benefitted immensely from Dr. Xiaoxiao Zhong’s deep analysis of the Mechanism of Resistance, especially in breast cancer. Her identification of novel prognostic biomarkers such as KLRB1 helps stratify patients more accurately, allowing clinicians to anticipate resistance-related outcomes before therapy begins. The Mechanism of Resistance in TME modeling has been at the heart of her biomarker discovery process, supporting patient-specific therapy protocols. Through gene-expression profiling, Zhong has uncovered patterns within resistant tumor populations, revealing how microenvironmental elements such as stromal and immune cells interact to foster resistance. These insights enable the classification of molecular subtypes and open avenues for personalized medicine. Her impact also extends to public repositories like the GEO database, where her models have been independently validated. Importantly, her work shines in translational relevance—where research moves from bench to bedside. She continuously examines the Mechanism of Resistance from various biological angles, ensuring a comprehensive understanding of cancer progression. This dedication not only enhances biomarker precision but reshapes diagnostic frameworks across oncology. With each study, Zhong solidifies her reputation as a forward-thinking researcher who blends innovation with applicability, driven by the persistent question: how do we decode and defeat the Mechanism of Resistance in cancer?

🏅 ACCOLADES, AFFILIATIONS, AND PROFESSIONAL RECOGNITION

Dr. Xiaoxiao Zhong’s academic and professional excellence has earned her increasing recognition both nationally and internationally. Her focus on the Mechanism of Resistance has gained the attention of peers and scientific bodies, resulting in collaborations with prestigious institutions like the National Natural Science Foundation of China. Though early in her career, she has already published seven high-impact SCI and Scopus-indexed journal articles that frequently reference the Mechanism of Resistance as a central analytical theme. Zhong’s expertise also led to an appointment as a reviewer for Case Reports in Obstetrics and Gynecology, confirming her command in evaluating complex biomedical literature. She is an active member of the Chinese Association of Pathophysiology, where she contributes insights on the Mechanism of Resistance in metabolic dysfunctions and immune escape. Her reputation is further validated by multiple citations and collaborations across various interdisciplinary projects, demonstrating the applicability of her work. While she has not yet published books or patents, the rigor and innovation in her findings promise future expansion into these domains. Through her growing network and academic contributions, Zhong continues to shape the research landscape—always with the Mechanism of Resistance as the analytical compass guiding her toward discovery and recognition.

🌍 GLOBAL RELEVANCE AND SCIENTIFIC INFLUENCE

Dr. Zhong’s research impact goes beyond national borders, as her emphasis on the Mechanism of Resistance contributes to the global scientific understanding of cancer biology. By leveraging high-throughput technologies and integrative analytics, she provides blueprints for other researchers seeking to decipher resistance pathways. Her 22-gene TMERS model has become a reference point for scientists studying tumor heterogeneity and immunological factors across populations. The international community increasingly cites her work, appreciating the way it refines the conceptualization of the Mechanism of Resistance across diverse genetic and environmental contexts. Zhong’s influence lies in her ability to connect the molecular dots between immune signaling, metabolic flux, and therapeutic failure. These connections not only elevate her research’s relevance but also inspire adaptations of her model into other cancer types. Her collaborations with global datasets and open-access platforms enhance reproducibility and transparency in science. Moreover, by showcasing how the Mechanism of Resistance is both a molecular and clinical phenomenon, she encourages a more holistic treatment strategy that transcends national health systems. Dr. Zhong’s scientific influence lies not only in her publications but also in her capacity to shape a universal language around resistance—making her a cornerstone of the new age of precision oncology.

🌱 FUTURE DIRECTIONS AND LEGACY IN BIOMEDICINE

Looking ahead, Dr. Xiaoxiao Zhong aims to deepen her exploration of the Mechanism of Resistance through next-generation sequencing, single-cell analysis, and AI-driven modeling. Her vision includes creating adaptive therapeutic strategies that consider dynamic changes within the tumor microenvironment. She aspires to develop resistance-interrupting drugs informed by biomarker-based predictions and functional genomics. Her legacy will likely be defined by her persistence in unraveling the Mechanism of Resistance and translating it into viable treatment solutions. With growing citation indices and expanding collaborations, Zhong’s influence is poised to transform clinical practices and research methodologies alike. Her efforts are gradually building a blueprint for integrating systems biology into oncology clinics. While continuing to train and mentor young researchers, she aims to establish a resistance research consortium to pool global resources in this domain. By doing so, she ensures that future scientists inherit a solid foundation of knowledge and practical frameworks for targeting the Mechanism of Resistance in multiple disease contexts. In summary, her career is not just a collection of publications—it’s an evolving legacy grounded in inquiry, collaboration, and the relentless pursuit of overcoming the Mechanism of Resistance at every biological and clinical junction.

NOTABLE PUBLICATION

  • Title: Glycosylated protein-related microenvironmental features in breast cancer are associated with patient prognosis
    Author: Xiaoxiao Zhong et al.
    Journal: Mammalian Genome
    Date: 2025-05-24

 

  • Title: PCMT1 confirmed as a pan-cancer immune biomarker and a contributor to breast cancer metastasis
    Author: Xiaoxiao Zhong (with contributor Yiqi Liu)
    Journal: American Journal of Cancer Research
    Date: 2024

 

  • Title: Interpretable machine learning model based on the systemic inflammation response index and ultrasound features can predict central lymph node metastasis in cN0T1–T2 papillary thyroid carcinoma
    Author: Xiaoxiao Zhong et al.
    Journal: Gland Surgery
    Date: 2023-11

 

  • Title: Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer
    Author: Xiaoxiao Zhong et al.
    Journal: Cell Death Discovery
    Date: 2023-09-25

 

  • Title: Breast cancer combined with contralateral neck lymph node metastasis: a case report
    Author: Xiaoxiao Zhong et al.
    Journal: Diagnostic Pathology
    Date: 2022-12

Derya GĂĽzel ErdoÄźan – Plant Disease Modelling – Best Researcher Award

Derya GĂĽzel ErdoÄźan - Plant Disease Modelling - Best Researcher Award

Sakarya University - Turkey

AUTHOR PROFILE

ORCID

🌱 EARLY ACADEMIC PURSUITS

DERYA GÜZEL ERDOĞAN's academic journey began with a solid foundation in medicine, earning her Bachelor's degree from Ondokuz Mayıs University in 2008. With a natural inclination toward physiological sciences, she advanced to complete her specialization at Ankara University's Department of Physiology in 2013. Her doctoral thesis, which investigated the effects of intermittent hypoxia on the cardiac HIF/VEGF pathway in Type 1 Diabetes Mellitus, reflects her early commitment to research at the intersection of cardiology and molecular biology. Her work during this period foreshadowed a career defined by meticulous inquiry and innovation in experimental physiology. Through rigorous scientific training, Erdoğan honed both her research and clinical skills, preparing herself to tackle complex questions in pathophysiology, especially those related to inflammation, ischemia-reperfusion injury, and metabolic diseases. These early experiences provided a deep understanding of translational medicine and laid the groundwork for her future exploration of cellular signaling and therapeutic interventions.

đź§Ş RESEARCH EXCELLENCE AND FOCUS

ERDOĞAN’s research portfolio spans an impressive range of physiological and biomedical topics, with a notable emphasis on inflammation, oxidative stress, ischemia-reperfusion injury, and angiogenesis. Her pioneering studies delve into the molecular mechanisms of diseases such as psoriatic arthritis, schizophrenia, thyroid cancer, and myocardial infarction. Her work frequently involves investigating angiogenetic molecules like VEGF, HIF, and HO-1, aiming to understand their roles in inflammation and tissue regeneration. She has been principal investigator or collaborator in numerous TÜBİTAK and university-funded projects, showcasing her ability to translate fundamental physiology into potential clinical applications. Among her distinguished research themes is the modulation of systemic inflammation and oxidative damage using phytochemicals like hesperidin, apocynin, and rosmarinic acid. Her studies provide essential insights into how plant-based compounds can serve as protective agents in various disease models. Erdoğan’s ongoing research continues to shed light on complex physiological interactions, particularly in the domains of neuroendocrinology, reproductive physiology, and immune responses.

🧑‍🏫 PROFESSIONAL ENDEAVORS

As a dedicated academic, Derya Güzel Erdoğan has served in key roles across Sakarya University’s Faculty of Medicine, notably within the Department of Physiology. Rising from a research assistant at Ankara University to an assistant professor and later an associate professor at Sakarya, she exemplifies academic leadership. From 2015 to 2018, she was Head of the Physiology Department, reflecting trust in her administrative and academic capabilities. Erdoğan has mentored multiple postgraduate theses, guiding students in experimental models of rheumatoid arthritis, angiogenesis, and inflammatory signaling pathways. Her pedagogical commitment is also evident in her contributions to physiology education and her co-authorship of scientific book chapters on topics like exercise physiology, calcium homeostasis, and neurohormonal signaling. Her teaching, firmly grounded in current research, bridges theory and practice, encouraging students to critically engage with emerging physiological paradigms. She has also collaborated across disciplines, contributing to physiology’s intersection with psychiatry, endocrinology, and cardiology.

🧬 SCIENTIFIC CONTRIBUTIONS AND COLLABORATIONS

Erdoğan has authored or co-authored over 40 articles in international peer-reviewed journals, consistently contributing to high-impact fields like psychoneuroendocrinology, reproductive physiology, and inflammation research. Her collaborative work often integrates biochemical analysis, histopathological techniques, and behavioral models, enabling multifaceted exploration of disease states. Whether examining neurotrophic factors in bipolar disorder or the interplay of Klotho and BDNF in cannabinoid users, her contributions reflect a robust interdisciplinary approach. Several of her studies address systemic disorders with a molecular lens, such as the NILCO pathway in thyroid cancer and the vascular implications of cytokines in rheumatoid arthritis. Erdoğan’s involvement in congresses and symposia underscores her role as a knowledge disseminator, where she presents cutting-edge findings and engages in global scientific discourse. She has also been a key figure in investigating the therapeutic value of natural compounds, championing their role in experimental models of arthritis, ischemia, and oxidative injury.

🏆 ACCOLADES AND RECOGNITION

Throughout her career, Erdoğan has earned multiple awards acknowledging her contributions to science and academia. Notably, she received the second-place research award at the 10th International Congress on Psychopharmacology in 2018, recognizing her innovative exploration of neuroendocrine markers in psychiatric disorders. She was also honored in Sakarya University’s “Medicine of the Future III” poster competition, placing third for her work in experimental physiology. These accolades reflect both her commitment to scientific rigor and the broader impact of her research on physiological and clinical sciences. Her ability to connect laboratory findings with potential clinical applications makes her a standout figure in experimental medicine. Moreover, her active membership in the Turkish Physiological Sciences Society attests to her engagement in advancing national scientific standards. Erdoğan’s recognition is not only a testament to her technical expertise but also to her perseverance, mentorship, and scholarly influence within the biomedical research community.

🌍 IMPACT AND INFLUENCE

Derya Güzel Erdoğan’s research has influenced several domains of physiology and medical science, particularly in understanding the interface between oxidative stress, inflammation, and tissue repair. Her findings on neuroplasticity, metabolic disorders, and reproductive physiology have been cited by researchers seeking to develop novel interventions for complex pathologies. Her emphasis on integrative physiology—connecting molecular signals to systemic outcomes—offers a model for translational research. By examining how dietary, hormonal, and pharmacological agents influence disease processes, Erdoğan contributes to a better understanding of how to prevent and manage chronic inflammatory and degenerative conditions. Her role in experimental designs that utilize animal models to simulate human diseases has equipped many young researchers with the tools and methodologies needed to pursue independent scientific inquiry. Her influence extends beyond publications—she shapes research ethics, inspires collaborative science, and provides a blueprint for future scientists eager to bridge laboratory findings with real-world health challenges.

đź”® LEGACY AND FUTURE CONTRIBUTIONS

As Erdoğan continues to explore new frontiers in experimental physiology, her legacy is being defined by both scientific depth and mentorship. She is currently engaged in national projects funded by TÜBİTAK, focusing on the interplay of gut microbiota, cardiovascular remodeling, and hormonal balance in experimental disease models. Her foresight in selecting impactful research topics ensures that her work remains both relevant and visionary. Erdoğan’s legacy will be marked not only by her publications and grants but also by the many students and colleagues she has mentored, who carry forward her passion for translational physiology. With a firm grounding in empirical rigor and a vision oriented toward holistic understanding of disease mechanisms, she is poised to make continued contributions to personalized medicine, especially in the context of inflammation, neurobiology, and endocrine function. Her future research promises to further unravel the complex interplay between physiological systems, leading to better-targeted and more effective therapeutic strategies.

NOTABLE PUBLICATION

  • Title: Effects of different doses of Ganoderic Acid A on nociceptive behaviour and inflammatory parameters in polyarthritic mice rheumatoid arthritis model
    Authors: Erdogan, Derya Guzel; Demir, Aysenur; Baylan, Huseyin; Budak, Ozcan; Cokluk, Erdem; Tanyeri, Pelin
    Journal: Scientific Reports

 

  • Title: Promising Antidepressant Potential: The Role of Lactobacillus rhamnosus GG in Mental Health and Stress Response
    Authors: Isik, Musab; Kose, Fadime; Ozbayer, Cansu; Budak, Ozcan; Kaya, Rumeysa Keles; Erdogan, Derya Guzel; Demirci, Mehmet Arif; Doganay, Songul; Bagci, Cahit
    Journal: Probiotics and Antimicrobial Proteins

 

  • Title: Relationship between klotho, neurotrophic factors (BDNF, NGF, GDNF) and cognitive functions in patients with bipolar disorder
    Authors: Celebi, Zeynep; Yazici, Esra; Erdogan, Derya Guzel; Davutoglu, Onur; Yazici, Ahmet Bulent
    Journal: BMC Psychiatry

 

  • Title: The protective effects of hesperidin pretreatment on kidney and remote organs against renal ischemia-reperfusion injury
    Authors: Karacaer, C.; Erdogan, D. G.; Tanyeli, A.; Baylan, H.; Eraslan, E.; Guler, M. C.; Polat, E.; Comakli, S.
    Journal: European Review for Medical and Pharmacological Sciences

 

  • Title: An Overview of Ischemia-Reperfusion Injury: Review on Oxidative Stress and Inflammatory Response
    Authors: Guler, Mustafa Can; Tanyeli, Ayhan; Akdemir, Fazile Nur Ekinci; Eraslan, Ersen; Sebin, Saime Ozbek; Erdogan, Derya Guzel; Nacar, Tuncer
    Journal: The Eurasian Journal of Medicine